Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide

Despite substantial progress in the prevention of group B Streptococcus (GBS) disease with the introduction of intrapartum antibiotic prophylaxis, this pathogen remains a leading cause of neonatal infection. Capsular polysaccharide conjugate vaccines have been tested in phase I/II clinical studies,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Proc Natl Acad Sci U S A
Päätekijät: Carboni, Filippo, Adamo, Roberto, Fabbrini, Monica, De Ricco, Riccardo, Cattaneo, Vittorio, Brogioni, Barbara, Veggi, Daniele, Pinto, Vittoria, Passalacqua, Irene, Oldrini, Davide, Rappuoli, Rino, Malito, Enrico, Margarit, Immaculada y Ros, Berti, Francesco
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: National Academy of Sciences 2017
Aiheet:
Biological Sciences
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441712/
https://ncbi.nlm.nih.gov/pubmed/28439022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1701885114
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia